Sofia Mubarika became a staff in the Histology and Cell Biology Department, after graduating from Medical Education at the FK UGM, in 1974. In 1981, she received a Histology Brevet as a Histologist. In 1985, Sofia received her Master for Medical Science (M.Med.Sc) from Auckland University of Medical School New Zealand in the field of Immunobiology. In 1987, he attended the Biology of Parasitism Summer Course in Woods Hole, Massachusetts USA, where she explored Immunology and Molecular Biology for 8 weeks. PhD in the field of Cancer Molecular Genetics was obtained from Kobe University Medical School Japan in 1994. Research on the relationship between Epstein Barr Virus and Nasopharyngeal cancer was initiated in 1997 with a group of teams from several departments at FK UGM and Dr. Sardjito Hospital by involving several  Master of Biotechnology and Doctor of Medicine UGM students (URGE Batch 2). This was followed by a collaboration with VUmc and AvL, funded by KWF to build the capacity of human resources in various clinics at FK UGM and Dr. Sardjito Hospital. In 2003, she received funding from the European Community (EU) for nasopharyngeal cancer in collaboration with several foreign institutions such as the Netherlands (AvL, VUmc), France (IGR) and the Karolinska Institute. She graduated her students not only PhD from UGM, but also from UI, and Netherlands (UI, AvL). She has graduated many Masters Degree students in Biomedicine, Biotechnology and Doctorate from various institutions in Indonesia. Since 2011, Sofia has focused more on research on microRNA-based cancer biomarkers until now. Produced 3 patents and a number of reputable international publications. Beside that, Sofia is also active in developing translational cancer research until now. Sofia is also a member of the Health Sciences Commission of the Indonesian Academy of Sciences until now. She is the Research Reviewer Team for Litbangkes and DIPI until now. During the Covid pandemic, participated in the development of the RI-GHA antibody-based rapid test, resulting in 1 patents used to assist in the serosurveillance, also post-vaccination.

e-mail address: sofia.mubarika@ugm.ac.id